Transdermal administration of phycotoxins

Details Transdermal administration of phycotoxins Transdermal administration of phycotoxins

A - Human Necessities

61

K

A61K 31/505 (2006.01) A61F 2/00 (2006.01)

Patent

CA 2607206

Pharmaceutical compositions for interfering with neuronal transmission comprising an effective amount of at least one tricyclic 3,4- propinoperhydropurine are disclosed. Preparations for facial rejuvenation are provided that comprise an effective amount of the composition of the invention and a facial cream. Methods of interfering with neuronal transmission comprising topical application of an effective amount of the pharmaceutical compositions of the invention are provided. In another aspect of the invention, effective amounts of the pharmaceutical compositions and a transdermal therapeutic system are provided for transdermal administration of at least one tricyclic 3,4-propinoperhydropurine. The pharmaceutical composition contains at least one at least one tricyclic 3,4- propinoperhydropurine, and may be formulated for transdermal drug delivery. The transdermal drug delivery system may be a laminated composite comprising a backing layer, a drug reservoir, and a means for affixing the composite to the skin.

L'invention concerne des compositions pharmaceutiques destinées à interférer avec la transmission neuronale et comprenant une dose efficace d'au moins une 3,4-propinoperhydropurine tricyclique. L'invention concerne également des préparations pour le rajeunissement du visage comprenant une dose efficace de la composition de l'invention ainsi qu'une crème pour le visage. Elle se rapporte en outre à des méthodes destinées à interférer avec la transmission neuronale et consistant à réaliser l'application topique d'une dose efficace des compositions pharmaceutiques de l'invention. Dans un autre aspect, l'invention concerne des doses efficaces de ces compositions pharmaceutiques et un système thérapeutique transdermique pour l'administration transdermique d'au moins une 3,4-propinoperhydropurine tricyclique. La composition pharmaceutique contient au moins une 3,4-propinoperhydropurine tricyclique et peut être préparée en vue d'une administration médicamenteuse transdermique. Le système d'administration transdermique peut être un composite stratifié comprenant une couche de support, un réservoir de médicament et un élément permettant de fixer ce composite sur la peau.

Affiliated with

Also associated with

Rating

Transdermal administration of phycotoxins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal administration of phycotoxins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal administration of phycotoxins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1359813